Correlation Between Inverse Sp and Biotechnology Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inverse Sp and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inverse Sp and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inverse Sp 500 and Biotechnology Fund Class, you can compare the effects of market volatilities on Inverse Sp and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inverse Sp with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inverse Sp and Biotechnology Fund.

Diversification Opportunities for Inverse Sp and Biotechnology Fund

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Inverse and Biotechnology is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Inverse Sp 500 and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Inverse Sp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inverse Sp 500 are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Inverse Sp i.e., Inverse Sp and Biotechnology Fund go up and down completely randomly.

Pair Corralation between Inverse Sp and Biotechnology Fund

Assuming the 90 days horizon Inverse Sp 500 is expected to under-perform the Biotechnology Fund. But the mutual fund apears to be less risky and, when comparing its historical volatility, Inverse Sp 500 is 1.91 times less risky than Biotechnology Fund. The mutual fund trades about -0.21 of its potential returns per unit of risk. The Biotechnology Fund Class is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,982  in Biotechnology Fund Class on May 5, 2025 and sell it today you would earn a total of  176.00  from holding Biotechnology Fund Class or generate 4.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inverse Sp 500  vs.  Biotechnology Fund Class

 Performance 
       Timeline  
Inverse Sp 500 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inverse Sp 500 has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Biotechnology Fund Class 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Fund Class are ranked lower than 4 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Inverse Sp and Biotechnology Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inverse Sp and Biotechnology Fund

The main advantage of trading using opposite Inverse Sp and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inverse Sp position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.
The idea behind Inverse Sp 500 and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm